Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benefits and Risks of Bariatric Surgery in Adults
David Arterburn, Dana A. Telem, Robert F. Kushner, et al.
JAMA (2020) Vol. 324, Iss. 9, pp. 879-879
Closed Access | Times Cited: 838

Showing 1-25 of 838 citing articles:

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4265
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4232
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1573
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 914
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies, et al.
JAMA (2021) Vol. 325, Iss. 14, pp. 1414-1414
Open Access | Times Cited: 729
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery
Dan Eisenberg, Scott A. Shikora, Edo O. Aarts, et al.
Surgery for Obesity and Related Diseases (2022) Vol. 18, Iss. 12, pp. 1345-1356
Open Access | Times Cited: 505
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
P. Barton Duell, Francine K. Welty, Michael Miller, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 6
Open Access | Times Cited: 397
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph, Prakash Deedwania, Tushar Acharya, et al.
Circulation (2022) Vol. 145, Iss. 9
Open Access | Times Cited: 387
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery
Dan Eisenberg, Scott A. Shikora, Edo O. Aarts, et al.
Obesity Surgery (2022) Vol. 33, Iss. 1, pp. 3-14
Open Access | Times Cited: 373
Contemporary medical, device, and surgical therapies for obesity in adults
Carolina M. Perdomo, Ricardo V. Cohen, Priya Sumithran, et al.
The Lancet (2023) Vol. 401, Iss. 10382, pp. 1116-1130
Closed Access | Times Cited: 365
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Rexiati Ruze, Tiantong Liu, Xi Zou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 326
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Yang Wang, Qiukui Hao, et al.
The Lancet (2021) Vol. 399, Iss. 10321, pp. 259-269
Closed Access | Times Cited: 239
Treatment of Hypertension
Robert M. Carey, Andrew E. Moran, Paul K. Whelton
JAMA (2022) Vol. 328, Iss. 18, pp. 1849-1849
Closed Access | Times Cited: 221
Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery
Jamil S. Samaan, Yee Hui Yeo, Nithya Rajeev, et al.
Obesity Surgery (2023) Vol. 33, Iss. 6, pp. 1790-1796
Open Access | Times Cited: 193
Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
Sophie L. van Veldhuisen, Thomas M. Gorter, Gijs van Woerden, et al.
European Heart Journal (2022) Vol. 43, Iss. 20, pp. 1955-1969
Open Access | Times Cited: 180
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment
Sabrena Noria, Rita D. Shelby, Katelyn D. Atkins, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 3, pp. 31-42
Open Access | Times Cited: 95
New insights into the treatment of obesity
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 91
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 773-791
Open Access | Times Cited: 91
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Anders Boisen Jensen, Frida Renström, Stefan Aczél, et al.
Obesity Surgery (2023) Vol. 33, Iss. 4, pp. 1017-1025
Open Access | Times Cited: 89
Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies
Ailin Luo, Zheng Xie, Yue Wang, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 137, pp. 104642-104642
Closed Access | Times Cited: 84
Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis
Tingting Yan, Yuhong Luo, Nana Yan, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 239-255
Open Access | Times Cited: 71
Obesity in adults
Ildiko Lingvay, Ricardo V. Cohen, Carel W. le Roux, et al.
The Lancet (2024) Vol. 404, Iss. 10456, pp. 972-987
Closed Access | Times Cited: 62
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 274-286.e10
Open Access | Times Cited: 52
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Yang Wang, Qiukui Hao, et al.
The Lancet (2024) Vol. 403, Iss. 10434, pp. e21-e31
Closed Access | Times Cited: 51
Obesity: A Review of Pathophysiology and Classification
Bradley Busebee, Wissam Ghusn, Lizeth Cifuentes, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 12, pp. 1842-1857
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top